6月30日，Liquidia Technologies盘中上涨5.07%，报78.93美元/股，成交额3370.43万美元。消息面上，此前一交易日美银证券将公司评级从"买入"下调至"中性"，目标价设定为79美元，引发获利回吐导致股价一度跌逾5%至73美元附近。当前股价反弹至接近目标价水平，显示市场消化评级调整后的估值修复。
基本面方面，公司一季度EPS 0.52美元，超预期的0.41美元，核心产品YUTREPIA净产品销售额约1.3亿美元，同比扭亏为盈，独立患者处方超4500份。此外，公司将在PHA国际肺动脉高压大会上发布海报数据，学术会议催化叠加业绩高增预期，支撑市场对短期超跌后的回补情绪。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.